Exo Therapeutics is a startup based in the United States, 1 tracked investor.
Based in the United States, Exo Therapeutics is a startup. Brouky records 1 investor associated with the company.
Exo Therapeutics is a small molecule drug discovery and development company using a proprietary platform to identify and develop inhibitors that target enzyme exosites for oncology and inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.